![]() Investigate the efficacy and safety of runcaciguat (BAY 1101042) in patients with moderately Phase 2 study to evaluate the safety and efficacy of OPL-0401 in patients with non-proliferative diabetic retinopathy OPL-0401 is an oral, small molecule ROCK1/2 inhibitor in development for the treatment of diabetic retinopathyĬ Identifier: NCT05383209Ī Phase 2, Multicenter, Prospective, Double-masked, Parallel Study of EYP-1901, a Tyrosine Kinase Inhibitor (TKI), compared to ShamĬ Identifier: NCT04722991Ī Phase 2 randomized, placebo-controlled, double-masked proof-of-concept study to Phase 3, Double-masked, Randomized Study to Evaluate the Efficacy and Safety of Intravitreal OPT-302 (a fusion protein targeting VEGF-C and VEGF-D) in Combination with Lucentis, Compared with Lucentis AloneĪ Triple-masked, Randomized trial to Evaluate the effect of Fenofibrate, a cholesterol medication, compared with placebo for prevention of diabetic retinopathy (DR) worsening Of EYP-1901, a Tyrosine Kinase Inhibitor (TKI), Compared to Aflibercept in Subjects with Wet AMDĬ Identifier: NCT04757610 Phase IV study designed to assess the response to treatment with SUSVIMO Q24W in patients with nAMD who have been previously treated with anti-VEGF agents other than ranibizumab.Ĭ Identifier: NCT05381948Ī Phase 2, Multicenter, Prospective, Randomized, Double-Masked, Parallel Study (Protocol RGX-314-3101) “Ascent”Ĭ Identifier: NCT05407636Ī Randomized, Partially Masked, Controlled, Phase 3 Clinical Study to Evaluate the Efficacy and Safety of RGX-314 Gene Therapy in Participants with nAMD. RGX-314 vs ranibizumab in the treatment of wAMD If you’d like more information on any of the trials below, please fill out our contact form and indicate which trial you’re interested in.Ĭ Identifier: NCT04704921 Below are trials for which we are currently enrolling new patients. Our specialists are proud to take part in clinical research trials for many common retinal conditions. Clinical trials open for enrollment at Austin Retina. For individuals with few options or who aren’t seeing positive results, enrolling in a clinical trial provides access to the promising new vision therapies of tomorrow. At Austin Retina, we participate in clinical trials to offer new options, opportunities and hope for people who need them to protect, preserve or improve their eyesight. New methods and medications are constantly being developed to slow disease process, improve vision outcomes, and improve quality of life. Retinal care, like the field of medicine itself, is always advancing and changing. Why consider enrolling in a retina-related clinical trial? Every treatment in use today was investigated and approved for use through the clinical trials process, and all future medical treatments will have gone through this process. (Investigation begins in the laboratory, and promising methods may proceed to non-human testing and then human trials.) At the same time, patients enrolled in a new treatment’s clinical trial may be the first to benefit from that treatment. Trials are conducted in adherence to strict standards, and they are governed and reviewed by institutional review boards (IRBs), which exist to protect patients’ health and safety.Ĭlinical trials are one of the last steps in the careful, detailed process of studying a new treatment. Specifically, clinical trials determine whether a new medication, device or treatment strategy…ĭesigned for safety, accuracy and advancement of quality care.Ĭlinical trials are designed to produce the highest-quality data possible… while ensuring the safety of the patients in each study. The goal of clinical trials-whether for vision-related care or any other medical discipline-is to advance medical knowledge and help improve patient care. We pride ourselves on being at the forefront of clinical research and will always recognize the impact on those who benefit the most: our patients.įor referring doctors or patients who wish to learn more about our research protocols or activities, please continue reading below or contact our office at (512) 451-0103.Ĭlinical trials are scientific medical research into the appropriateness, effectiveness and safety of new treatments in humans. PVD, Retinal Holes, Tears or DetachmentsĪustin Retina puts patients first, with same-day appointments and 24/7 patient supportĬlinical Trials: Providing New Hope and Opportunity in The Face of Retinal Conditions Research at Austin RetinaĪustin Retina is nationally recognized for its participation in ground-breaking, pivotal clinical trials for over thirty years, which has allowed us to offer our patients the opportunity to receive novel procedures and therapies through enrollment in clinical research studies.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |